The Cochrane Collaboration
Cochrane Reviews
by sub-topics:

For complete list (no sub-topics), click here - Browse by sub-topic (Review Group)

Can't find a review topic below covering your question or interest? Suggest one:
*

Multiple Sclerosis Group (32)
Treatment (Pharmacological Interventions) (15)
Biologics (0)
Alemtuzumab (0)
Daclizumab (0)
Natalizumab (0)
Rituximab (0)
T-cell vaccination (0)
Non steroidal Anti-inflammatory Drugs (NSAIDS) (0)
Combination Therapies (0)
Seizures (0)
Symptomatic treatments (Pharmacological Interventions) (10)
Spasticity (1)
Benzodiazepine (0)
Botulinum toxin (0)
Muscle relaxant (0)
Bowel problems (0)
Depression/Anxiety/Insomnia (1)
Benzodiazepine (0)
Monoamine Oxidase Inhibitor (MAOI) (0)
Selective Serotonin Reuptake Inhibitor (SSRI) (0)
Tricyclic antidepressant (0)
Urinary problems (1)
Imipramine (0)
Propantheline (0)
Urinary frequency and urgency (0)
Desmopressin, Vasopressin (0)
Oxybutynin (0)
Urinary hesitancy (0)
Phenoxybenzamine (0)
Terazosin (0)
Urinary tract infections (UTI) (0)
Urinary urgency and incontinence (0)
Bethane (0)
Carbamazepine (0)
Imiprenine (0)
Tolterodine (0)
Dizziness and Vertigo (0)
Dimenhydrinate (0)
Diphenhydramine (0)
Meclizine (0)
Prochlorperazine (0)
Scopolamine (0)
Fatigue (2)
Fluoxetine (0)
Modafinil (0)
Pemoline (0)
Pain and Dysaesthesia (1)
Amitriptyline (0)
Carbamazepine (0)
Desipramine (0)
Doxepin (0)
Gabapentin (0)
Imipramine (0)
Phentoin (0)
Protriptyline (0)
Topiramate (0)
Ziconotide (0)
Zonisamide (0)
Palliative Care (0)
Health services (0)
Comparison of intervention modalities (inpatient, outpatient, day-hospital, home treatment) (0)
Delivery of care (0)
Information provision to patients and caregivers (0)
Physical and transportation barriers (0)
Rehabilitation services (0)
Outcome Measures (0)
Clinical outcomes and natural history (0)
Immunological-devised outcomes (0)
Resonance Imaging-devised outcomes (0)
Treatment of co-morbid conditions (0)